Arachidonic acid induces ER stress and apoptosis in HT-29 human colon cancer cells.

Animal Cells and Systems
Sijeong BaeYoung-Ah Moon

Abstract

Polyunsaturated fatty acids (PUFAs) have important functions in biological systems. The beneficial effects of dietary PUFAs against inflammatory diseases, cardiovascular diseases, and metabolic disorders have been shown. Studies using cancer cells have presented the anti-tumorigenic effects of docosahexaenoic acid (DHA), an n-3 PUFA, while arachidonic acid (AA), an n-6 PUFA, has been shown to elicit both pro- and anti-tumorigenic effects. In the current study, the anti-tumorigenic effects of AA were evaluated in HT-29 human colon cancer cells. Upon adding AA in the media, more than 90% of HT-29 cells died, while the MCF7 cells showed good proliferation. AA inhibited the expression of SREBP-1 and its target genes that encode enzymes involved in fatty acid synthesis. As HT-29 cells contained lower basal levels of fatty acid synthase, a target gene of SREBP-1, than that in MCF7 cells, the inhibitory effects of AA on the fatty acid synthase levels in HT-29 cells were much stronger than those in MCF-7 cells. When oleic acid (OA), a monounsaturated fatty acid that can be synthesized endogenously, was added along with AA, the HT-29 cells were able to proliferate. These results suggested that HT-29 cells could not synthesize enough fat...Continue Reading

References

May 18, 1999·Current Opinion in Lipidology·J D Horton, I Shimomura
Dec 3, 1999·Prostaglandins, Leukotrienes, and Essential Fatty Acids·U N Das
Nov 22, 2000·The Journal of Biological Chemistry·V C HannahM S Brown
Dec 14, 2002·Journal of the American College of Nutrition·Artemis P Simopoulos
May 26, 2004·The American Journal of Clinical Nutrition·Susanna C LarssonAlicja Wolk
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joanne R Brown, Raymond N DuBois
Nov 19, 2005·Science·Maria Domenica CastelloneJ Silvio Gutkind
May 25, 2007·The New England Journal of Medicine·Andrew T ChanCharles S Fuchs
Aug 9, 2007·The American Journal of Clinical Nutrition·Angela M ZivkovicArun J Sanyal
May 17, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Megan N HallJing Ma
Oct 8, 2008·Journal of Lipid Research·Young-Ah MoonJay D Horton
Aug 13, 2009·JAMA : the Journal of the American Medical Association·Andrew T ChanCharles S Fuchs
Feb 22, 2012·Gastroenterology·Norie SawadaUNKNOWN Japan Public Health Center-Based Prospective Study Group
May 10, 2012·Journal of Nutrition and Metabolism·E PattersonC Stanton
Jun 12, 2013·International Journal of Oncology·Risa ShiragamiKeiji Koda
Jul 25, 2013·Trends in Cell Biology·Yani Chen, Federica Brandizzi
Nov 10, 2013·Postgraduate Medicine·William S HarrisTerrance J Moran
Sep 9, 2017·Biochemical and Biophysical Research Communications·Aiko TanakaNobuyuki Fukushima
Sep 14, 2017·Biochemical Society Transactions·Philip C Calder

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
PCR
reverse transcription-PCR

Software Mentioned

CFX [UNK]

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis